Viewing Study NCT06453902

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 4:06 AM

Ignite Modification Date: 2026-02-22 @ 7:25 AM

Study NCT ID: NCT06453902

Status: RECRUITING

Last Update Posted: 2025-02-21

First Post: 2024-05-28

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients

Sponsor: Shenzhen TargetRx, Inc.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module